Myeloperoxidase Inhibitor

• CAT Number: R032515
• CAS Number: 5351-17-7
• Molecular Formula: C7H9N3O
• Molecular Weight: 151.17
• Purity: ≥95%
• Synonyms: 4-Aminobenzoic acid hydrazide; 4-Aminobenzoyl hydrazide; 4-Aminobenzoylhydrazine; Amben hydrazide; Aminostimil; NSC 640; p-Aminobenzhydrazide; p-Aminobenzohydrazide; p-Aminobenzoic acid hydrazide; p-Aminobenzoic hydrazide; p-Aminobenzoylhydrazine
• Target: Metabolic Enzyme/Protease
• Storage: Room temperature
• IUPAC Name: 4-aminobenzohydrazide
• InChI: InChI=1S/C7H9N3O/c8-6-3-1-5(2-4-6)7(11)10-9/h1-4H,8-9H2,(H,10,11)
• InChIKey: WPBZMCGPFHZRHJ-UHFFFAOYSA-N
• SMILES: C1=CC(=CC=C1C(=O)NN)N

Myeloperoxidase Inhibitor（Cat No.:R032515） is a chemical compound used in pharmaceutical research for its potential therapeutic applications. Myeloperoxidase is an enzyme found in certain immune cells, such as neutrophils, and plays a role in the inflammatory response. Inhibiting myeloperoxidase activity is of interest in the development of drugs targeting inflammatory conditions. This inhibitor may help reduce the production of reactive oxygen species and other inflammatory mediators associated with myeloperoxidase activity. Research into myeloperoxidase inhibitors is ongoing, to discover new treatments for diseases involving excessive inflammation, such as cardiovascular diseases and certain autoimmune disorders.